0001140361-18-020306.txt : 20180427 0001140361-18-020306.hdr.sgml : 20180427 20180427193208 ACCESSION NUMBER: 0001140361-18-020306 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180322 FILED AS OF DATE: 20180427 DATE AS OF CHANGE: 20180427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K CENTRAL INDEX KEY: 0001238403 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 18786236 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4/A 1 doc1.xml FORM 4/A X0306 4/A 2018-03-22 2018-03-26 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001238403 SPIEGELMAN DANIEL K C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, Chief Financial Officer Common Stock 2018-03-22 2018-03-22 4 F 0 3598 81.36 D 73587 D This amendment is being filed solely to correct an administrative error in the original filing regarding the number of shares reported as forfeited. /s/ Laura Randall Woodhead, Attorney-in-Fact 2018-04-27